Personal tools

Coexpression cluster:C2530

From FANTOM5_SSTAR

Revision as of 17:37, 18 May 2012 by Autoedit (talk | contribs)
Jump to: navigation, search


Full id: C2530_Retinal_Mallassezderived_Bronchial_Keratinocyte_small_Hep2_Tracheal



Phase1 CAGE Peaks

Hg19::chr1:155278605..155278621,+p2@FDPS
Hg19::chr1:155278625..155278745,+p1@FDPS
Hg19::chr8:11660227..11660306,+p1@FDFT1
Hg19::chrX:151999599..151999615,+p1@NSDHL


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


No results for this coexpression

Enriched Gene Ontology terms on this co-expression cluster<b>Summary:</b> Results for GOStat analysis on co-expressed clusters. Each cluster with promoters mapping to at least two different genes was analysed with GOStat (PMID: 14962934) with default parameter. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br>data


GO IDGO nameFDR corrected p-value
GO:0006695cholesterol biosynthetic process2.35846206673679e-08
GO:0016126sterol biosynthetic process2.7973410948078e-08
GO:0008203cholesterol metabolic process2.60032406071113e-07
GO:0006694steroid biosynthetic process2.7490233849884e-07
GO:0016125sterol metabolic process2.7490233849884e-07
GO:0008202steroid metabolic process3.11636752412651e-06
GO:0008610lipid biosynthetic process8.93433186074538e-06
GO:0004659prenyltransferase activity9.14037355238191e-06
GO:0006066alcohol metabolic process1.66208797318529e-05
GO:0008299isoprenoid biosynthetic process1.95292984653651e-05
GO:0006720isoprenoid metabolic process3.13236575847922e-05
GO:0044255cellular lipid metabolic process6.42619524810821e-05
GO:0016765transferase activity, transferring alkyl or aryl (other than methyl) groups9.10383300825682e-05
GO:0006629lipid metabolic process0.000103018853577011
GO:0004310farnesyl-diphosphate farnesyltransferase activity0.000369789826916284
GO:0047012sterol-4-alpha-carboxylate 3-dehydrogenase (decarboxylating) activity0.000369789826916284
GO:0004337geranyltranstransferase activity0.000657384784818225
GO:0004161dimethylallyltranstransferase activity0.000657384784818225
GO:0004311farnesyltranstransferase activity0.00124549783979476
GO:0009058biosynthetic process0.00126128254597198
GO:00038543-beta-hydroxy-delta5-steroid dehydrogenase activity0.00309827870602796
GO:0022404molting cycle process0.00409408397409858
GO:0001942hair follicle development0.00409408397409858
GO:0042633hair cycle0.00409408397409858
GO:0042303molting cycle0.00409408397409858
GO:0022405hair cycle process0.00409408397409858
GO:0005783endoplasmic reticulum0.00519523953746089
GO:0016229steroid dehydrogenase activity0.0067557024387043
GO:0016491oxidoreductase activity0.0140882656807064
GO:0005737cytoplasm0.0238510504393937
GO:0008544epidermis development0.0256644984393836
GO:0007398ectoderm development0.0268795976235625
GO:0016616oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor0.0274868037710153
GO:0016614oxidoreductase activity, acting on CH-OH group of donors0.0285746974756521
GO:0016740transferase activity0.049679821594233
GO:0009888tissue development0.049679821594233



Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br>disease_data<br>


Cell Type
Ontology termp-valuen

Uber Anatomy
Ontology termp-valuen

Disease
Ontology termp-valuen


Overrepresented TFBS (DNA) motifs on this co-expression cluster<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs



JASPAR motifs

Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}



ENCODE TF ChIP-seq peak enrichment analysis<b>Summary:</b> For each TF and each co-expression cluster, the number of promoters with ENCODE TF ChIP signal was compared with the rest of promoters from the robust set using Fisher's exact test. Clusters with significant ChIP enrichment (q <= 0.05) after Benjamini-Hochberg correction were retained. <br><b>Analyst:</b> Erik Arner<br><br>link to source dataset<br><br>data


No analysis results for this cluster

Relative expression of the co-expression cluster<b>Summary:</b>Co-expression clusters are compared against FANTOM5 samples to obtain relative expression. <br><b>Analyst:</b>NA<br><br>link to data source<br> data


This analysis result is provided for C0 - C305 clusters.